Chunlai Lu

773 total citations
9 papers, 487 citations indexed

About

Chunlai Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chunlai Lu has authored 9 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Chunlai Lu's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Chunlai Lu is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Chunlai Lu collaborates with scholars based in China. Chunlai Lu's co-authors include Yin Li, Di Ge, Fengkai Xu, Qiaoliang Zhu, Di Ge, Yiwei Chen, Jie Gu, Hao Wu, Huazong Zeng and Qun Wang and has published in prestigious journals such as Nature Communications, PROTEOMICS and BMC Cancer.

In The Last Decade

Chunlai Lu

9 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunlai Lu China 7 381 192 132 86 45 9 487
Dalong Cao China 8 221 0.6× 148 0.8× 116 0.9× 68 0.8× 40 0.9× 18 361
Caroline Coghlin United Kingdom 6 205 0.5× 134 0.7× 106 0.8× 185 2.2× 41 0.9× 10 447
Dengyan Zhu China 15 393 1.0× 301 1.6× 102 0.8× 118 1.4× 74 1.6× 32 605
Jonathan Cimino Belgium 7 274 0.7× 276 1.4× 115 0.9× 67 0.8× 21 0.5× 8 434
Alyssa M. Klein United States 5 305 0.8× 152 0.8× 167 1.3× 120 1.4× 22 0.5× 6 442
Johannes C. van der Mijn Netherlands 14 321 0.8× 149 0.8× 145 1.1× 102 1.2× 27 0.6× 29 468
Simon Schallenberg Germany 10 199 0.5× 75 0.4× 92 0.7× 99 1.2× 65 1.4× 36 434
Yu‐Chen Pei China 9 300 0.8× 228 1.2× 100 0.8× 158 1.8× 17 0.4× 14 502
Sheng-Bang Yang China 10 218 0.6× 160 0.8× 88 0.7× 81 0.9× 18 0.4× 16 348

Countries citing papers authored by Chunlai Lu

Since Specialization
Citations

This map shows the geographic impact of Chunlai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlai Lu more than expected).

Fields of papers citing papers by Chunlai Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlai Lu. The network helps show where Chunlai Lu may publish in the future.

Co-authorship network of co-authors of Chunlai Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlai Lu. A scholar is included among the top collaborators of Chunlai Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlai Lu. Chunlai Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Yin, Li Luo, Yong Zhang, et al.. (2024). UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment. Nature Communications. 15(1). 1200–1200. 28 indexed citations
3.
Li, Yin, et al.. (2022). Exploring the role of m6A modification in cancer. PROTEOMICS. 23(13-14). e2200208–e2200208. 11 indexed citations
4.
Shu, Hong, Lei Zhang, Yiwei Chen, et al.. (2021). Quantification of Intact O-Glycopeptides on Haptoglobin in Sera of Patients With Hepatocellular Carcinoma and Liver Cirrhosis. Frontiers in Chemistry. 9. 705341–705341. 6 indexed citations
5.
Li, Yin, Fengkai Xu, Qiaoliang Zhu, et al.. (2020). Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma. Briefings in Bioinformatics. 22(4). 118 indexed citations
6.
Li, Yin, Di Ge, & Chunlai Lu. (2019). The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics & Chromatin. 12(1). 71–71. 174 indexed citations
7.
Xu, Fengkai, Shu Zhang, Jie Gu, et al.. (2019). TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma. BMC Cancer. 19(1). 875–875. 13 indexed citations
8.
Li, Yin, Di Ge, Jie Gu, et al.. (2019). A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. BMC Cancer. 19(1). 886–886. 57 indexed citations
9.
Wu, Hao, Rui Xue, Chunlai Lu, et al.. (2009). Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. Journal of Chromatography B. 877(27). 3111–3117. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026